Accéder au contenu
Merck

Pharmacokinetics of posaconazole in koalas (Phascolarctos cinereus) after intravenous and oral administration.

Journal of veterinary pharmacology and therapeutics (2017-04-30)
S Gharibi, B Kimble, L Vogelnest, J Barnes, C K Stadler, M Govendir
RÉSUMÉ

The pharmacokinetic profile of posaconazole in clinically normal koalas (n = 8) was investigated. Single doses of posaconazole were administered intravenously (i.v.; 3 mg/kg; n = 2) or orally (p.o.; 6 mg/kg; n = 6) with serial plasma samples collected over 24 and 36 hr, respectively. Plasma concentrations of posaconazole were quantified by validated high-performance liquid chromatography. A noncompartmental pharmacokinetic analysis of data was performed. Following i.v. administration, estimates of the median (range) of plasma clearance (CL) and steady-state volume of distribution (V

MATÉRIAUX
Numéro du produit
Marque
Description du produit

Supelco
Posaconazole, VETRANAL®, analytical standard